TOP CATEGORY: Chemicals & Materials | Life Sciences | Banking & Finance | ICT Media
Click for best price
Lipid-regulating drugs are used to treat dyslipidemias, cardiovascular problems, osteoporosis, and post-menopause complications.
This report contains market size and forecasts of Lipid-regulating Drugs in Global, including the following market information:
Global Lipid-regulating Drugs Market Revenue, 2017-2022, 2023-2028, ($ millions)
Global top five companies in 2021 (%)
The global Lipid-regulating Drugs market was valued at million in 2021 and is projected to reach US$ million by 2028, at a CAGR of % during the forecast period.
The U.S. Market is Estimated at $ Million in 2021, While China is Forecast to Reach $ Million by 2028.
Statins Segment to Reach $ Million by 2028, with a % CAGR in next six years.
The global key manufacturers of Lipid-regulating Drugs include AbbVie, Amgen, Andrx Corporation, AstraZeneca, Bristol-Myers Squibb, Merck, Novartis, Pfizer and Teva. etc. In 2021, the global top five players have a share approximately % in terms of revenue.
We surveyed the Lipid-regulating Drugs companies, and industry experts on this industry, involving the revenue, demand, product type, recent developments and plans, industry trends, drivers, challenges, obstacles, and potential risks.
Total Market by Segment:
Global Lipid-regulating Drugs Market, by Type, 2017-2022, 2023-2028 ($ millions)
Global Lipid-regulating Drugs Market Segment Percentages, by Type, 2021 (%)
Statins
Non-statins
Global Lipid-regulating Drugs Market, by Application, 2017-2022, 2023-2028 ($ millions)
Global Lipid-regulating Drugs Market Segment Percentages, by Application, 2021 (%)
Retail Pharmacies
Hospital Pharmacies
Online Pharmacies
Global Lipid-regulating Drugs Market, By Region and Country, 2017-2022, 2023-2028 ($ Millions)
Global Lipid-regulating Drugs Market Segment Percentages, By Region and Country, 2021 (%)
North America
US
Canada
Mexico
Europe
Germany
France
U.K.
Italy
Russia
Nordic Countries
Benelux
Rest of Europe
Asia
China
Japan
South Korea
Southeast Asia
India
Rest of Asia
South America
Brazil
Argentina
Rest of South America
Middle East & Africa
Turkey
Israel
Saudi Arabia
UAE
Rest of Middle East & Africa
Competitor Analysis
The report also provides analysis of leading market participants including:
Key companies Lipid-regulating Drugs revenues in global market, 2017-2022 (estimated), ($ millions)
Key companies Lipid-regulating Drugs revenues share in global market, 2021 (%)
Further, the report presents profiles of competitors in the market, key players include:
AbbVie
Amgen
Andrx Corporation
AstraZeneca
Bristol-Myers Squibb
Merck
Novartis
Pfizer
Teva
| Report Attributes | Report Details |
|---|---|
| Report Title | Lipid-regulating Drugs Market, Global Outlook and Forecast 2022-2028 |
| Historical Year | 2018 to 2022 (Data from 2010 can be provided as per availability) |
| Base Year | 2021 |
| Forecast Year | 2029 |
| Number of Pages | 66 Pages |
| Customization Available | Yes, the report can be customized as per your need. |
Frequently Asked Questions ?
